United Kingdom · Question · Written question
UIN 68968
Diabetes: Drugs
Introduced
17 July 2025
Last action
23 July 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 July 2025
Summary
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of Liraglutide for patients with type 2 diabetes; and what steps his Department is taking to ensure that patients with a
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 July 2025
Written question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of Liraglutide for patients with type 2 diabetes; and what steps his Department is taking to ensure that patients with a
Source: Commons
23 July 2025
Answer
One brand of liraglutide, Victoza, was discontinued in December 2024, although liraglutide injections remain available from other suppliers, who can support the full demand of the United Kingdom.The Department was aware of supply issues with GLP-1 recepto...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-07-17/68968
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1824649
- uk · wq-1824649 · source updated 23 July 2025